logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

20 New IPOs for Week of July 28

By  +Follow July 28, 2014 1:53PM
Share:
Tickers Mentioned:

Full IPO calendar & reports HERE.  In order of largest IPO first:

 

(1) Based in Stamford, CT, Synchrony Financial (SYF) scheduled a $3.06 billion IPO on the NYSE with a market capitalization of $20.3 billion at a price range midpoint of $24 for Thursday, July 31, 2014.

SYF is one of the premier consumer financial services companies in the United States. It's the old GE Capital.

 

(2) Based in Somerset, NJ, Catalent (CTLT) scheduled a $871 million IPO on the NYSE with a market capitalization of $2.4 billion at a price range midpoint of $20.50 for Thursday, July 31, 2014.

CTLT is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

 

(3) Based in Jerusalem, Israel, Mobileye N.V. (MBLY) scheduled a $500 million IPO on the NYSE with a market capitalization of $3.8 billion at a price range midpoint of $18 for Friday, August 1, 2014.

MBLY is the global leader in the design and development of software and related technologies for camera-based Advanced Driver Assistance Systems (“ADAS”).

 

(4) Based in London, United Kingdom, VTTI Energy Partners LP  (VTTI) scheduled a $350 million IPO on the NYSE, with a market capitalization of $402 million at a price range midpoint of $20 for Friday, August 1, 2014.

VTTI is a fee-based, growth-oriented limited partnership formed in April 2014 by VTTI, one of the world’s largest independent energy terminaling businesses, to own, operate, develop and acquire refined petroleum product and crude oil terminaling and related energy infrastructure assets on a global scale.

 

(5) Based in Aberdeen, United Kingdom,Transocean Partners (RIGP) scheduled a $350 million IPO on the NYSE with a market capitalization of $827 million at a price range midpoint of $20 for Thursday, July 31, 2014.

RIGP is a growth-oriented limited liability company recently formed by Transocean,one of the world’s largest offshore drilling contractors, to own, operate and acquire modern, technologically advanced offshore drilling rigs.

 

(6) Based in Houston, TX, Westlake Chemical Partners LP (WLKP) scheduled a $225 million IPO on the NYSE with a market capitalization of $508 milliion at a price range midpoint of $20 for Wednesday, July 30, 2014.

WLKP is a Delaware limited partnership recently formed by Westlake to operate, acquire and develop ethylene production facilities and related assets.

 

(7) Based in Weston, FL, FCB Financial Holdings (FCB) scheduled a $223 million IPO on the NYSE with a market capitalization of $1.02 billion at a price range midpoint of $25.50 for Friday, August 1, 2014.

 

(8) Based in Oakbrook Terrace, IL, SIRVA (SRVA) scheduled a $186 million IPO on the Nasdaq with a market capitalization of $632 million at a price range midpoint of $16 for Friday, August 1, 2014.

SRVA is a moving/relocation company.

 

(9) Based in North Billerica, MA, Lantheus Holdings (LNTH) scheduled a $125 million IPO on the Nasdaq with a market capitalization of $370 million at a price range midpoint of $13.50 for Wednesday, July 30, 2014.

LNTH is a global leader in developing, manufacturing, selling and distributing innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases.

 

(10) Based in Draper, UT, Health Equity (HQY) scheduled a $100 million IPO on the Nasdaq with a market capitalization of $546 million at a price range midpoint of $11 for Thursday, July 31, 2014.

HQY is a leader and an innovator in the high growth category of technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions.

 

(11) Based in Or Yehuda, Israel, Vascular Biogenics (VBLX) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $259 million at a price range midpoint of $14 for Thursday, July 31, 2014.

VBLX is a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.

 

(12) Based in Menlo Park, CA, Avalanche Biotechnologies (AAVL) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $292 million at a price range midpoint of $14 for Thursday, July 31, 2014.

AAVL is a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to transform the lives of patients with sight-threatening ophthalmic diseases.

 

(13) Based in Zug, Switzerland, Auris Medical Holding AG (EARS) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $283 million at a price range midpoint of $11 for Friday, August 1, 2014.

EARS is a clinical-stage biopharmaceutical company focused on the development of novel products for the treatment of inner ear disorders.

 

(14) Based in Petach Tikva, Israel, Macrocure (MCUR) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $264 million at a price range midpoint of $14 for Thursday, July 31, 2014.

MCUR is a regenerative medicine company focused on developing, manufacturing and commercializing novel cell therapy products to address unmet needs in the treatment of chronic and other hard-to-heal wounds.

 

(15) Based in Fremont, CA, Zosano Pharma (ZSAN) scheduled a $70 million IPO on the Nasdaq with a market capitalization of $134 million at a price range midpoint of $11 for $134 million for the week of July 28th.

ZSAN is a clinical stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of a variety of indications.

 

(16) Based in South San Francisco, CA, Tobira Therapeutics (TBRA) scheduled a $60 million IPO on the Nasdaq with a market capitalization of $143 million at a price range midpoint of $13 for Thursday, July 31, 2014.

TBRA is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat liver disease, human immunodeficiency virus, or HIV, fibrosis and inflammation.

 

(17) Based in Stamford, CT, Loxo Oncology (LOXO) scheduled a $57 million IPO on the Nasdaq with a market capitalization of $196 million at a price range midpoint of $13 for Friday, August 1, 2014.

LOXO develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations.

 

(18) Based in New Haven, CT, Marinus Pharmaceuticals (MRNS) scheduled a $52 million IPO on the Nasdaq with a market capitalization of $159 million at a price range midpoint of $13 for Thursday, July 31, 2014.

MRNS is a clinical stage biopharmaceutical company focused on developing and commercializing innovative neuropsychiatric therapeutics.

 

(19) Based in Tel Aviv, Israel, Bio Blast Pharma Ltd. (ORPN) scheduled a $40 million IPO on the Nasdaq with a market capitalization of $172 million at a price range midpoint of $172 for Friday, Aug. 1, 2014.

ORPN is a development-stage biopharmaceutical company focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases.

 

(20) Based in Yonker, NY, ContraFect (CFRXU) scheduled a $20 million IPO on the Nasdaq with a market capitalization of $96 million at a price range midpoint of $5.50 for Tuesday, July 29, 2014.

CFRXU is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for SYF
US Banking News
24 Oct 14 15:18:44
Synchrony Financial Sets New 52-Week High at $26.36 $SYF http://t.co/ikyEOX5ram
HotKeyTrading
24 Oct 14 10:00:11
All-Time Highs: $FISV $GILD $TFX $TYL $PG $EW $MTX $ABBV $SYF $OCR $IDXX $MMM $TUBE $MUSA $TMH http://t.co/XQITF0lRKD #trader #watchlist
HotKeyTrading
24 Oct 14 09:00:07
Annual Highs: $GILD $TFX $TYL $PG $CRL $DRIV $BJRI $MTX $ABBV $SYF $OCR $IDXX $LHO $HNT $MMM http://t.co/XQITF0lRKD #investing #daytrading
Leslie Picker
24 Oct 14 07:51:45
ICYMI -- @EDexheimer's profile on the second female CEO of a bank valued at $10 bln+ $SYF | http://t.co/j109ytHwIR
Ivan B. Beljan
24 Oct 14 07:01:51
Scaled down longs again, tilted account more bearish. $BKW and $SYF only full long positions
AlphaNotBeta
24 Oct 14 06:51:20
$SYF look at it go.
AlphaNotBeta
23 Oct 14 07:01:24
$SYF beasting.
WKRB News
23 Oct 14 01:48:22
Synchrony Financial Short Interest Up 117.8% in September $SYF http://t.co/3LZ2Wy9eHz
InterCooler
23 Oct 14 00:50:57
Synchrony Financial Sees Significant Increase in Short Interest $SYF http://t.co/pkzpdYv54U
US Banking News
23 Oct 14 00:39:00
Synchrony Financial Sees Significant Increase in Short Interest $SYF http://t.co/LKEuXK1ClX
4-traders.com
22 Oct 14 22:36:08
Synchrony Financial : Posts Third Annual Major Purchase Consumer Study http://t.co/Di88Cr9TE3 $SYF
Ivan B. Beljan
22 Oct 14 11:49:22
$SYF hod http://t.co/PcNn7uMzAN
NASDAQ
22 Oct 14 07:40:10
$SYF - Synchrony Financial Forecasts Moderate 2014 Holiday Retail Sales Growth of 3.5 Percent http://t.co/SCZZD0u1Lx
4-traders.com
22 Oct 14 07:40:06
Synchrony Financial : Forecasts Moderate 2014 Holiday Retail Sales Growth of 3.5 Percent http://t.co/0Gm2n8T9H5 $SYF
Lisa Wolfson
22 Oct 14 06:08:00
RT @cr_harper: Cop’s daughter tuned in to ESPN on her road to becoming a top U.S. bank CEO http://t.co/Shbj5dpOEL via @EDexheimer @Bloomber…
Ticker Report
22 Oct 14 04:58:31
Synchrony Financial Earns Neutral Rating from Nomura $SYF http://t.co/beuxIscVek
Zubeyr Kamil Açıksar
22 Oct 14 04:23:29
RT @cr_harper: Cop’s daughter tuned in to ESPN on her road to becoming a top U.S. bank CEO http://t.co/Shbj5dpOEL via @EDexheimer @Bloomber…
Christine Harper
22 Oct 14 04:22:51
Cop’s daughter tuned in to ESPN on her road to becoming a top U.S. bank CEO http://t.co/Shbj5dpOEL via @EDexheimer @BloombergNews $SYF
Seeking Alpha
21 Oct 14 11:46:59
Update: Synchrony Financial Q3 Earnings http://t.co/8Fr7BPcouI $SYF
ETF Trends
20 Oct 14 14:40:07
IPO #ETF to Add Shares of #Zayo Group http://t.co/oCrxXVCE4n #ipos #ETFs $IPO $ZAYO $BABA $CFG $MBLY $SYF $IPOS
Tom Lydon
20 Oct 14 14:35:05
IPO #ETF to Add Shares of #Zayo Group http://t.co/zv1wKukCyi #ipos #ETFs $IPO $ZAYO $BABA $CFG $MBLY $SYF $IPOS
WKRB News
20 Oct 14 08:23:14
Synchrony Financial Given “Neutral” Rating at Nomura $SYF http://t.co/0tDmd47j7g
4-traders.com
20 Oct 14 07:35:05
Synchrony Financial : Third Annual Major Purchase Consumer Study Shows Confidence on the Rise (Cautious but... http://t.co/XrhDITuIKo $SYF
NASDAQ
20 Oct 14 07:31:10
$SYF - Cautious but Climbing: Synchrony Financial’s Third Annual Major Purchase Consumer Study Shows http://t.co/m1KWQCeCwX
US Banking News
20 Oct 14 07:26:33
Synchrony Financial Rating Reiterated by Nomura $SYF http://t.co/WzzVMOAVCq
InterCooler
20 Oct 14 07:21:49
Synchrony Financial’s Neutral Rating Reiterated at Nomura $SYF http://t.co/oDLbL5hKsR
US Consumer News
20 Oct 14 07:19:27
Synchrony Financial's neutral rating reiterated at Nomura. $25.00 PT. http://t.co/TrJVMbVMJ5 $SYF #SYF
Analyst Ratings
20 Oct 14 07:19:00
Synchrony Financial's neutral rating reiterated at Nomura. $25.00 PT. http://t.co/lILVbwgTqj $SYF #SYF
4-traders.com
20 Oct 14 04:35:16
GE Reports 3Q'14 Operating EPS $0.38, +6% 3Q Industrial Profit +9% http://t.co/BWExcbkUX0 $GE $SYF $ALO
WKRB News
20 Oct 14 04:34:39
Synchrony Financial $SYF Posts Quarterly Results http://t.co/WC1lrULJau
Bidness Etc
18 Oct 14 04:47:42
Synchrony Financial Q3 Earnings Ahead Of Street View - http://t.co/MRcbEXkKuP $SYF
equities.com
17 Oct 14 12:29:39
General Electric Surges After Shedding Financial Division $GE $SYF http://t.co/x0aahrzFUX
Rohit Gupta
17 Oct 14 10:06:39
GE's Oil & Gas, Aviation Divisions Propel Q3 Earnings http://t.co/jTHkEuoiy3 #IBDNews via @IBDinvestors $GE $SYF $HON
Social Alpha Inc
17 Oct 14 08:59:38
Hottest stocks on social media: $CECO $SYF $MTB $NWBI $ESI $MS $REGN $HON $CCL. Trade social buzz @ http://t.co/K98K1bULdq #tradeSentiment
Matt Bartolotta
17 Oct 14 08:44:09
GE's Oil & Gas, Aviation Divisions Propel Q3 Earnings http://t.co/F9gcGNDBK8 #IBDNews via @IBDinvestors $GE $SYF $HON
AlphaNotBeta
17 Oct 14 08:12:45
$GE had a gem in $SYF.
Briefing.com
17 Oct 14 08:09:08
$SYF: Synchrony Financial beats by $0.03 http://t.co/Zsr7zku52h
Quantheta
17 Oct 14 08:00:06
#VOLUMESHIFTUP $ESI $HBAN $STI $URBN $HON $TXT $KSU $COCO $SYF $BK #quantheta
MarketCurrents
17 Oct 14 07:25:20
Synchrony Financial higher after first post-IPO earnings report http://t.co/V7tnVEoHbX $SYF
Mark Palmer
17 Oct 14 07:15:11
$syf Reports 3Q14 Earnings Beat Driven by Strong Growth Metrics in First Quarterly Report Following IPO http://t.co/8maz2ltUGK
Sleek Money
17 Oct 14 07:08:25
Synchrony Financial $SYF Releases Quarterly Earnings, Beats Expectations By $0.03 EPS http://t.co/xlbN2Us5DG
US Banking News
17 Oct 14 06:42:28
Synchrony Financial announces earnings. $0.70 EPS. Beats estimates. $2.19b revenue. http://t.co/GB1bydrXqy $SYF #SYF
Nicole F Johnson
17 Oct 14 06:40:27
RT @SYFNews: $SYF Reports Third Quarter Net Earnings of $548 Million or $0.70 Per Diluted Share http://t.co/eBKatpBjgT http://t.co/br44c4K1…
Cristy F Williams
17 Oct 14 06:37:49
RT @SYFNews: $SYF Reports Third Quarter Net Earnings of $548 Million or $0.70 Per Diluted Share http://t.co/eBKatpBjgT http://t.co/br44c4K1…
Samuel Wang
17 Oct 14 06:23:52
RT @SYFNews: $SYF Reports Third Quarter Net Earnings of $548 Million or $0.70 Per Diluted Share http://t.co/eBKatpBjgT http://t.co/br44c4K1…
Peyton T. Wylie
17 Oct 14 06:23:11
RT @JodyLurie: #EarningsSeason: $GE (slightest beat), $SYF, $STI (beat), $MS (strong beat), $BK (beat), $TXT (beat)
Adrian N
17 Oct 14 06:20:58
RT @SeekingAlpha: Update: General Electric Brings Good Things To Earnings http://t.co/RQIn45keKj $SYF $GE
MarketCurrents
17 Oct 14 06:16:42
Synchrony Financial beats by $0.04, beats on revenue http://t.co/zbgm3JIenn #premarket $SYF
Synchrony Financial
17 Oct 14 06:14:50
$SYF Reports Third Quarter Net Earnings of $548 Million or $0.70 Per Diluted Share http://t.co/eBKatpBjgT http://t.co/br44c4K1ao
Jody Lurie
17 Oct 14 06:13:57
#EarningsSeason: $GE (slightest beat), $SYF, $STI (beat), $MS (strong beat), $BK (beat), $TXT (beat)
				
				
By  +Follow July 28, 2014 1:53PM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.